Stevanato (STVN): Utang-utang marang kapitalisasi buku

Stevanato Group S.p.A. (STVN) produces glass containers for medications using unique ampoule sterilization methods, which are critical for FDA compliance. Its status as a global favorite in vial production ensures perpetual demand due to the complexity of switching certified partners. This price chart captures the 0.29 metric, while the production of biopharmaceutical cartridges guarantees a steady profit stream and an excess of free cash flow.

STVN (Stevanato Group Corp) riwayat Utang marang nilai buku saka 04.07.2022 nganti 28.10.2026

Ringkesan rincian data analitis Stevanato Group SpA (STVN)

- rega lan prakiraan konsensus rega:

Rega saham Stevanato Group S.p.A.|STVN - Prakiraan gabungan firma investasi

- data kapitalisasi pasar:

Kapitalisasi pasar Stevanato Group Corp|STVN - Rega Tumbas Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham Stevanato Group|STVN - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku stevanatogroup.com|STVN - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Stevanato Group S.p.A.|STVN - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Stevanato|STVN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Stevanato Group Corp

Analisis fundamental perusahaan:Stevanato Group S.p.A.

To select reliable assets, it is essential for an investor to assess the stability of the capital structure via the ratio of total liabilities to the company's book value. This ratio of borrowed funds to book capitalization measures the debt load, which for Stevanato Group S.p.A. (STVN) remains manageable due to inelastic demand for pharmaceutical packaging, thereby minimizing default risks during business expansion.

Karo sapa Stevanato Group S.p.A. saingan